FamiCord AG
Company Profile
Business description
FamiCord AG is an umbilical cord blood bank. It supplies cryopreservation and provides logistics for the collection of blood, preparation, and storage of stem cells from umbilical cord blood and tissue. The company is active in the areas of cell and gene therapies and CDMO. It continues to develop from a pure stem cell bank into a more broadly based cell bank that can supply available patients own cells for current and future cell therapies. Its services include stem cells banking, stem cells scientific proof, FamiCord contribution, stem cell applications list, stem cell applications stories, and stem cells banking for society. Its segments include Subgroup Vita 34 and Subgroup PBKM, which generate maximum revenue. It operates in Germany, Poland, Switzerland, and other foreign countries.
Contact
Perlickstrase 5
LeipzigD-04103
DEUT: +49 34148792
Sector
Healthcare
Stock type
Defensive
Industry
Medical Care Facilities
Fiscal Year End
31 December 2026
Employees
742
Stocks News & Analysis
stocks
Alphabet raises $80 billion for AI efforts
stocks
SpaceX: What investors need to know about its enormous upcoming IPO
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 9,017.20 | 3.10 | -0.03% |
| CAC 40 | 8,180.02 | 29.07 | -0.35% |
| DAX 40 | 24,870.70 | 253.47 | -1.01% |
| Dow JONES (US) | 51,307.79 | 228.91 | 0.45% |
| FTSE 100 | 10,333.16 | 40.35 | -0.39% |
| HKSE | 25,633.21 | 405.11 | -1.56% |
| NASDAQ | 27,093.90 | 7.09 | 0.03% |
| Nikkei 225 | 68,402.13 | 1,667.89 | 2.50% |
| NZX 50 Index | 13,115.08 | 55.63 | -0.42% |
| S&P 500 | 7,609.78 | 9.82 | 0.13% |
| S&P/ASX 200 | 8,785.70 | 5.90 | 0.07% |
| SSE Composite Index | 4,083.97 | 8.87 | 0.22% |